Insulet Income from Continuous Operations 2010-2024 | PODD

Insulet annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Insulet income from continuous operations for the quarter ending December 31, 2024 was $0.101B, a 2.52% decline year-over-year.
  • Insulet income from continuous operations for the twelve months ending December 31, 2024 was $0.418B, a 102.76% increase year-over-year.
  • Insulet annual income from continuous operations for 2024 was $0.418B, a 102.76% increase from 2023.
  • Insulet annual income from continuous operations for 2023 was $0.206B, a 4384.78% increase from 2022.
  • Insulet annual income from continuous operations for 2022 was $0.005B, a 72.62% decline from 2021.
Insulet Annual Income from Continuous Operations
(Millions of US $)
2024 $418
2023 $206
2022 $5
2021 $17
2020 $7
2019 $12
2018 $3
2017 $-27
2016 $-27
2015 $-62
2014 $-48
2013 $-45
2012 $-52
2011 $-46
2010 $-61
2009 $-72
Insulet Quarterly Income from Continuous Operations
(Millions of US $)
2024-12-31 $101
2024-09-30 $78
2024-06-30 $189
2024-03-31 $52
2023-12-31 $103
2023-09-30 $52
2023-06-30 $27
2023-03-31 $24
2022-12-31 $17
2022-09-30 $-5
2022-06-30 $-35
2022-03-31 $28
2021-12-31 $29
2021-09-30 $13
2021-06-30 $-25
2021-03-31
2020-12-31 $-17
2020-09-30 $12
2020-06-30 $14
2020-03-31 $-2
2019-12-31 $5
2019-09-30 $1
2019-06-30 $1
2019-03-31 $4
2018-12-31 $10
2018-09-30 $2
2018-06-30 $-2
2018-03-31 $-7
2017-12-31 $-7
2017-09-30 $-2
2017-06-30 $-8
2017-03-31 $-10
2016-12-31 $-9
2016-09-30 $-3
2016-06-30 $-4
2016-03-31 $-11
2015-12-31 $-16
2015-09-30 $-18
2015-06-30 $-17
2015-03-31 $-10
2014-12-31 $-2
2014-09-30 $-11
2014-06-30 $-29
2014-03-31 $-6
2013-12-31 $-3
2013-09-30 $-21
2013-06-30 $-11
2013-03-31 $-11
2012-12-31 $-10
2012-09-30 $-12
2012-06-30 $-14
2012-03-31 $-15
2011-12-31 $-14
2011-09-30 $-14
2011-06-30 $-8
2011-03-31 $-10
2010-12-31 $-21
2010-09-30 $-12
2010-06-30 $-14
2010-03-31 $-14
2009-12-31 $-16
2009-09-30 $-17
2009-06-30 $-20
2009-03-31 $-20
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.332B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $227.162B 27.40
Boston Scientific (BSX) United States $140.689B 37.90
Stryker (SYK) United States $132.255B 28.42
EssilorLuxottica (ESLOY) France $128.431B 0.00
Medtronic (MDT) Ireland $105.938B 15.47
Lonza Group Ag (LZAGY) Switzerland $47.424B 0.00
Haleon (HLN) United Kingdom $46.151B 26.20
ResMed (RMD) United States $31.269B 24.08
Agilent Technologies (A) United States $29.217B 19.30
GE HealthCare Technologies (GEHC) United States $28.556B 13.89
Terumo (TRUMY) Japan $28.160B 0.00
Koninklijke Philips (PHG) Netherlands $22.192B 15.85
Zimmer Biomet Holdings (ZBH) United States $19.373B 12.24
Baxter (BAX) United States $14.818B 10.66
Smith & Nephew SNATS (SNN) United Kingdom $11.356B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Lantheus Holdings (LNTH) United States $6.938B 17.06
Bio-Rad Laboratories (BIO) United States $6.672B 23.10
Demant (WILYY) Denmark $6.644B 0.00
Prestige Consumer Healthcare (PBH) United States $3.977B 18.98
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.455B 9.89
ICU Medical (ICUI) United States $3.400B 29.07
Haemonetics (HAE) United States $2.872B 13.52
Envista Holdings (NVST) United States $2.614B 20.80
GN Store Nord (GNNDY) Denmark $2.188B 14.75
LeMaitre Vascular (LMAT) United States $1.946B 44.47
QuidelOrtho (QDEL) United States $1.698B 14.22
AtriCure (ATRC) United States $1.565B 0.00
Kestra Medical Technologies (KMTS) United States $1.214B 0.00
Green Thumb Industries (GTBIF) United States $1.189B 18.67
AdaptHealth (AHCO) United States $1.051B 10.12
BioLife Solutions (BLFS) United States $1.041B 0.00
InMode (INMD) Israel $1.038B 8.67
Neogen (NEOG) United States $0.953B 12.19
Phibro Animal Health (PAHC) United States $0.700B 10.74
Evolus (EOLS) United States $0.686B 0.00
Curaleaf Holdings (CURLF) Canada $0.649B 0.00
Valneva SE (VALN) France $0.552B 0.00
Owens & Minor (OMI) United States $0.535B 4.56
CeriBell (CBLL) United States $0.532B 0.00
Capricor Therapeutics (CAPR) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.450B 0.00
Surmodics (SRDX) United States $0.394B 0.00
Omeros (OMER) United States $0.394B 0.00
SNDL (SNDL) Canada $0.368B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Cresco Labs (CRLBF) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.302B 13.07
Viemed Healthcare (VMD) United States $0.262B 23.68
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 15.65
Sanuwave Health (SNWV) United States $0.256B 0.00
Verano Holdings (VRNOF) United States $0.251B 0.00
Aurora Cannabis (ACB) Canada $0.250B 44.40
Cerus (CERS) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Quanterix (QTRX) United States $0.200B 0.00
Canopy Growth (CGC) Canada $0.189B 0.00
High Tide (HITI) Canada $0.187B 0.00
Biote (BTMD) United States $0.181B 4.12
TriSalus Life Sciences (TLSI) United States $0.175B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.24
Brainsway (BWAY) Israel $0.155B 48.47
Jin Medical (ZJYL) China $0.147B 0.00
Organigram Global (OGI) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.123B 15.42
Agape ATP (ATPC) $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
TerrAscend (TSNDF) Canada $0.083B 0.00
Exagen (XGN) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Veru (VERU) United States $0.078B 0.00
Fonar (FONR) United States $0.076B 10.65
Zynex (ZYXI) United States $0.066B 24.22
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.063B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
United-Guardian (UG) United States $0.038B 11.61
Apyx Medical (APYX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Rockwell Medical (RMTI) United States $0.035B 51.50
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.010B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00